LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons
A growing number of genes associated with Parkinson’s disease are implicated in the regulation of lysosome function, including LRRK2, whose missense mutations are perhaps the most common monogenic cause of this neurodegenerative disease. These mutations are collectively thought to introduce a pathol...
Main Authors: | Anwesha Sanyal, Hailey S. Novis, Emile Gasser, Steven Lin, Matthew J. LaVoie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2020.00442/full |
Similar Items
-
mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
by: Robert A. Brown, et al.
Published: (2019-10-01) -
Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease
by: Manasa P. Srikanth, et al.
Published: (2020-12-01) -
An iPSC-based neural model of sialidosis uncovers glycolytic impairment-causing presynaptic dysfunction and deregulation of Ca2+ dynamics
by: Haruki Odaka, et al.
Published: (2021-05-01) -
“LRRK2: Autophagy and Lysosomal Activity”
by: Marta Madureira, et al.
Published: (2020-05-01) -
Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models
by: Tetsuro Abe, et al.
Published: (2021-06-01)